Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Targeting breast cancer stem cells.

McDermott SP, Wicha MS.

Mol Oncol. 2010 Oct;4(5):404-19. doi: 10.1016/j.molonc.2010.06.005. Epub 2010 Jun 17. Review.

2.

Cancer stem cells: the 'Achilles heel' of chemo-resistant tumors.

Hong IS, Lee HY, Nam JS.

Recent Pat Anticancer Drug Discov. 2015;10(1):2-22. Review.

PMID:
25479037
3.

Breast cancer stem cells: an update.

Iqbal J, Chong PY, Tan PH.

J Clin Pathol. 2013 Jun;66(6):485-90. doi: 10.1136/jclinpath-2012-201304. Epub 2013 Jan 15. Review.

PMID:
23322821
4.

Stem cells in breast tumours: are they ready for the clinic?

Ablett MP, Singh JK, Clarke RB.

Eur J Cancer. 2012 Sep;48(14):2104-16. doi: 10.1016/j.ejca.2012.03.019. Epub 2012 Apr 26. Review.

PMID:
22542086
5.

MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.

Xia H, Hui KM.

Cancer Gene Ther. 2012 Nov;19(11):723-30. doi: 10.1038/cgt.2012.58. Epub 2012 Sep 14. Review.

PMID:
22975591
6.

Regulation of ovarian cancer stem cells or tumor-initiating cells.

Kwon MJ, Shin YK.

Int J Mol Sci. 2013 Mar 25;14(4):6624-48. doi: 10.3390/ijms14046624. Review.

7.

Targeting the perpetrator: breast cancer stem cell therapeutics.

Pal A, Valdez KE, Carletti MZ, Behbod F.

Curr Drug Targets. 2010 Sep;11(9):1147-56. Review.

8.

Prostate cancer stem cell biology.

Yu C, Yao Z, Jiang Y, Keller ET.

Minerva Urol Nefrol. 2012 Mar;64(1):19-33. Review.

9.

Insights into the cell of origin in breast cancer and breast cancer stem cells.

Lindeman GJ, Visvader JE.

Asia Pac J Clin Oncol. 2010 Jun;6(2):89-97. doi: 10.1111/j.1743-7563.2010.01279.x. Review.

PMID:
20565420
10.

Novel therapeutic strategies for targeting liver cancer stem cells.

Oishi N, Wang XW.

Int J Biol Sci. 2011 Apr 26;7(5):517-35. Review.

11.

The hitchhikers guide to cancer stem cell theory: markers, pathways and therapy.

Fábián Á, Vereb G, Szöllősi J.

Cytometry A. 2013 Jan;83(1):62-71. doi: 10.1002/cyto.a.22206. Epub 2012 Sep 20. Review.

12.

Inflammatory signaling pathways in self-renewing breast cancer stem cells.

Hinohara K, Gotoh N.

Curr Opin Pharmacol. 2010 Dec;10(6):650-4. doi: 10.1016/j.coph.2010.08.003. Review.

PMID:
20817605
13.

Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression.

Bourguignon LY, Shiina M, Li JJ.

Adv Cancer Res. 2014;123:255-75. doi: 10.1016/B978-0-12-800092-2.00010-1. Review.

PMID:
25081533
14.

Targeting Notch to target cancer stem cells.

Pannuti A, Foreman K, Rizzo P, Osipo C, Golde T, Osborne B, Miele L.

Clin Cancer Res. 2010 Jun 15;16(12):3141-52. doi: 10.1158/1078-0432.CCR-09-2823. Epub 2010 Jun 8. Review.

15.

MicroRNA control of epithelial-mesenchymal transition in cancer stem cells.

Hao J, Zhang Y, Deng M, Ye R, Zhao S, Wang Y, Li J, Zhao Z.

Int J Cancer. 2014 Sep 1;135(5):1019-27. doi: 10.1002/ijc.28761. Epub 2014 Feb 19. Review.

16.

Breast cancer stem cells, EMT and therapeutic targets.

Kotiyal S, Bhattacharya S.

Biochem Biophys Res Commun. 2014 Oct 10;453(1):112-6. doi: 10.1016/j.bbrc.2014.09.069. Epub 2014 Sep 26. Review.

PMID:
25261721
17.

Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.

Ranji P, Salmani Kesejini T, Saeedikhoo S, Alizadeh AM.

Tumour Biol. 2016 Oct;37(10):13059-13075. Epub 2016 Aug 26. Review.

PMID:
27561758
18.

New approaches to target cancer stem cells: current scenario.

Insan MB, Jaitak V.

Mini Rev Med Chem. 2014 Jan;14(1):20-34. Review.

PMID:
24195662
19.

Current status and issues in cancer stem cell study.

Yang YM, Chang JW.

Cancer Invest. 2008 Aug;26(7):741-55. doi: 10.1080/07357900801901856. Review.

PMID:
18608212
20.

Cervical cancer stem cells: opportunities and challenges.

Chhabra R.

J Cancer Res Clin Oncol. 2015 Nov;141(11):1889-97. doi: 10.1007/s00432-014-1905-y. Epub 2015 Jan 7. Review.

PMID:
25563493

Supplemental Content

Support Center